Product Information

DASATINIB 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $23.2023 per EA under NDC 59651054630. Its NADAC has been published 72 times since Jul 9, 2025.

FDA first approved this application on Apr 22, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DASATINIB 100 MG TABLET

DASATINIB
$23.2023per EA

Strength

100 mg/1

NDC

59651054630

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DASATINIB

Approval Type

Generic (ANDA)

FDA Application

ANDA216547

FDA Approved

4/22/2025

TE Code

AB

On Market Since

4/22/2025

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Protein Kinase Inhibitors

Price Statistics

The NADAC for DASATINIB 100 MG TABLET has been published 72 times since Jul 9, 2025, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.

Current price$23.2023 per EA
All-time high$191.7363 (Dec 10, 2025)
All-time low$23.2023 (Nov 18, 2026)
52-week high$191.7363
52-week low$23.2023
Median price$29.5711
Average price$80.0065
Largest weekly change-84.2% (Dec 17, 2025)
Weeks tracked72
Tracking sinceJul 9, 2025

Price History

1W

-3.7%

1M

-12.3%

3M

-11.4%

6M

-14.0%

1Y

-87.9%

3Y

N/A

5Y

N/A

All

-87.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DASATINIB market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DASATINIB 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DASATINIB 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $23.2023 per EA (NDC 59651054630), effective Nov 18, 2026.

How has the price of DASATINIB 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for DASATINIB 100 MG TABLET has declined 87.9%. It has been tracked across 72 weekly CMS publications since Jul 9, 2025.

What are the highest and lowest recorded NADAC prices for DASATINIB 100 MG TABLET?

Since Jul 9, 2025, the NADAC for DASATINIB 100 MG TABLET has ranged from a low of $23.2023 (Nov 18, 2026) to a high of $191.7363 (Dec 10, 2025), with a median of $29.5711 per EA.

Are there cheaper alternatives to DASATINIB 100 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of DASATINIB 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DASATINIB 100 MG TABLET?

DASATINIB 100 MG TABLET (NDC 59651054630) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.